{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:59:26Z","timestamp":1789718366431,"version":"4.0.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,11,2]],"date-time":"2007-11-02T00:00:00Z","timestamp":1193961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2407-7-204","type":"journal-article","created":{"date-parts":[[2007,11,2]],"date-time":"2007-11-02T19:23:57Z","timestamp":1194031437000},"source":"Crossref","is-referenced-by-count":18,"title":["Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins"],"prefix":"10.1186","volume":"7","author":[{"given":"Marcia R","family":"Saban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Ihnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Saban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,2]]},"reference":[{"issue":"3","key":"854_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0090-4295(99)00162-4","volume":"54","author":"KM Peters","year":"1999","unstructured":"Peters KM, Diokno AC, Steinert BW: Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette-Guerin treat interstitial cystitis by altering the immune profile in the bladder?. Urology. 1999, 54 (3): 450-453. 10.1016\/S0090-4295(99)00162-4.","journal-title":"Urology"},{"issue":"1 Suppl 1","key":"854_CR2","first-page":"17","volume":"14","author":"RP Huben","year":"1996","unstructured":"Huben RP: Intravesical chemotherapy versus immunotherapy for superficial bladder cancer. Semin Urol Oncol. 1996, 14 (1 Suppl 1): 17-22.","journal-title":"Semin Urol Oncol"},{"issue":"9165","key":"854_CR3","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","volume":"353","author":"AB Alexandroff","year":"1999","unstructured":"Alexandroff AB, Jackson AM, O'Donnell MA, James K: BCG immunotherapy of bladder cancer: 20 years on. Lancet. 1999, 353 (9165): 1689-1694. 10.1016\/S0140-6736(98)07422-4.","journal-title":"Lancet"},{"issue":"6","key":"854_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0090-4295(91)80166-5","volume":"38","author":"R De Jager","year":"1991","unstructured":"De Jager R, Guinan P, Lamm D, Khanna O, Brosman S, De Kernion J, Williams R, Richardson C, Muenz L, Reitsma D, Hanna MG: Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials. Urology. 1991, 38 (6): 507-513. 10.1016\/0090-4295(91)80166-5.","journal-title":"Urology"},{"issue":"11","key":"854_CR5","first-page":"1617","volume":"10","author":"HB Grossman","year":"1996","unstructured":"Grossman HB: Superficial bladder cancer: decreasing the risk of recurrence. Oncology (Williston Park). 1996, 10 (11): 1617-1624. discussion 1624, 1627\u20131618","journal-title":"Oncology (Williston Park)"},{"issue":"3","key":"854_CR6","first-page":"611","volume":"19","author":"DN Mitropoulos","year":"2005","unstructured":"Mitropoulos DN: Novel insights into the mechanism of action of intravesical immunomodulators. In Vivo. 2005, 19 (3): 611-621.","journal-title":"In Vivo"},{"issue":"5","key":"854_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1182\/blood-2005-03-1281","volume":"106","author":"V Abadie","year":"2005","unstructured":"Abadie V, Badell E, Douillard P, Ensergueix D, Leenen PJ, Tanguy M, Fiette L, Saeland S, Gicquel B, Winter N: Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood. 2005, 106 (5): 1843-1850. 10.1182\/blood-2005-03-1281.","journal-title":"Blood"},{"key":"854_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2172-8-6","volume":"8","author":"MR Saban","year":"2007","unstructured":"Saban MR, Simpson C, Davis CA, Wallis G, Knowlton N, Frank MB, Centola M, Gallucci RM, Saban R: Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG). BMC Immunol. 2007, 8 (): 6-10.1186\/1471-2172-8-6.","journal-title":"BMC Immunol"},{"issue":"4","key":"854_CR9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","volume":"91","author":"RF Bevers","year":"2004","unstructured":"Bevers RF, Kurth KH, Schamhart DH: Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br J Cancer. 2004, 91 (4): 607-612.","journal-title":"Br J Cancer"},{"issue":"3","key":"854_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00299717","volume":"20","author":"DH Schamhart","year":"1992","unstructured":"Schamhart DH, Kurth KH, de Reijke TM, Vleeming R: BCG treatment and the importance of an inflammatory response. Urol Res. 1992, 20 (3): 199-203. 10.1007\/BF00299717.","journal-title":"Urol Res"},{"issue":"4 Pt 1","key":"854_CR11","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/01.ju.0000140193.95528.91","volume":"172","author":"G Zhang","year":"2004","unstructured":"Zhang G, Chen F, Xu Y, Cao Y, Crist S, McKerrow A, Iwamoto Y, See WA: Autocrine over expression of fibronectin by human transitional carcinoma cells impairs bacillus Calmette-Guerin adherence and signaling. J Urol. 2004, 172 (4 Pt 1): 1496-1500. 10.1097\/01.ju.0000140193.95528.91.","journal-title":"J Urol"},{"issue":"12","key":"854_CR12","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/sj.bjc.6601474","volume":"89","author":"H Atkins","year":"2003","unstructured":"Atkins H, Davies BR, Kirby JA, Kelly JD: Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: a potential therapeutic regime for bladder cancer immunotherapy. Br J Cancer. 2003, 89 (12): 2312-2319. 10.1038\/sj.bjc.6601474.","journal-title":"Br J Cancer"},{"issue":"2","key":"854_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1158\/0008-5472.CAN-03-1518","volume":"64","author":"T Akazawa","year":"2004","unstructured":"Akazawa T, Masuda H, Saeki Y, Matsumoto M, Takeda K, Tsujimura K, Kuzushima K, Takahashi T, Azuma I, Akira S, Toyoshima K, Seya T: Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice. Cancer Res. 2004, 64 (2): 757-764. 10.1158\/0008-5472.CAN-03-1518.","journal-title":"Cancer Res"},{"issue":"3","key":"854_CR14","first-page":"177","volume":"42","author":"X Li","year":"2004","unstructured":"Li X, Gong ZY, Li H, Wei Q, Shi M, Yang YR: [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell]. Zhonghua wai ke za zhi [Chinese journal of surgery]. 2004, 42 (3): 177-181.","journal-title":"Zhonghua wai ke za zhi [Chinese journal of surgery]"},{"issue":"3","key":"854_CR15","first-page":"415","volume":"8","author":"JJ Patard","year":"1998","unstructured":"Patard JJ, Guille F, Lobel B, Abbou CC, Chopin D: [Current state of knowledge concerning the mechanisms of action of BCG]. Prog Urol. 1998, 8 (3): 415-421.","journal-title":"Prog Urol"},{"issue":"3","key":"854_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1086\/431603","volume":"192","author":"M Moreau","year":"2005","unstructured":"Moreau M, Lestage J, Verrier D, Mormede C, Kelley KW, Dantzer R, Castanon N: Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J Infect Dis. 2005, 192 (3): 537-544. 10.1086\/431603.","journal-title":"J Infect Dis"},{"issue":"10","key":"854_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJM199803053381002","volume":"338","author":"R Bellamy","year":"1998","unstructured":"Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV: Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med. 1998, 338 (10): 640-644. 10.1056\/NEJM199803053381002.","journal-title":"N Engl J Med"},{"issue":"2","key":"854_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nri1270","volume":"4","author":"GA Taylor","year":"2004","unstructured":"Taylor GA, Feng CG, Sher A: p47 GTPases: regulators of immunity to intracellular pathogens. Nat Rev Immunol. 2004, 4 (2): 100-109. 10.1038\/nri1270.","journal-title":"Nat Rev Immunol"},{"key":"854_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.23.021704.115653","volume":"23","author":"AW Segal","year":"2005","unstructured":"Segal AW: How neutrophils kill microbes. Annu Rev Immunol. 2005, 23: 197-223. 10.1146\/annurev.immunol.23.021704.115653.","journal-title":"Annu Rev Immunol"},{"issue":"5645","key":"854_CR20","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1126\/science.1088063","volume":"302","author":"JD MacMicking","year":"2003","unstructured":"MacMicking JD, Taylor GA, McKinney JD: Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science. 2003, 302 (5645): 654-659. 10.1126\/science.1088063.","journal-title":"Science"},{"issue":"4","key":"854_CR21","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0022-5347(05)00653-1","volume":"175","author":"M Decobert","year":"2006","unstructured":"Decobert M, Larue H, Bergeron A, Harel F, Pfister C, Rousseau F, Lacombe L, Fradet Y: Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol. 2006, 175 (4): 1506-1511. 10.1016\/S0022-5347(05)00653-1.","journal-title":"J Urol"},{"issue":"4","key":"854_CR22","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0022-5347(06)00054-1","volume":"175","author":"M O'Donnell","year":"2006","unstructured":"O'Donnell M: Entrez into the immunogenetics of superficial bladder cancer response to bacillus Calmette-Guerin. J Urol. 2006, 175 (4): 1197-1198. 10.1016\/S0022-5347(06)00054-1.","journal-title":"J Urol"},{"issue":"2","key":"854_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0022-5347(01)64576-2","volume":"158","author":"SA Kadhim","year":"1997","unstructured":"Kadhim SA, Chin JL, Batislam E, Karlik SJ, Garcia B, Skamene E: Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor. J Urol. 1997, 158 (2): 646-652. 10.1016\/S0022-5347(01)64576-2.","journal-title":"J Urol"},{"issue":"8","key":"854_CR24","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.4049\/jimmunol.157.8.3559","volume":"157","author":"SM Vidal","year":"1996","unstructured":"Vidal SM, Pinner E, Lepage P, Gauthier S, Gros P: Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J Immunol. 1996, 157 (8): 3559-3568.","journal-title":"J Immunol"},{"issue":"1","key":"854_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6793-6-1","volume":"6","author":"MR Saban","year":"2006","unstructured":"Saban MR, Hellmich HL, Turner M, Nguyen NB, Vadigepalli R, Dyer DW, Hurst RE, Centola M, Saban R: The inflammatory and normal transcriptome of mouse bladder detrusor and mucosa. BMC Physiol. 2006, 6 (1): 1-10.1186\/1472-6793-6-1.","journal-title":"BMC Physiol"},{"key":"854_CR26","unstructured":"Clontech Smart PCR. [ http:\/\/www.clontech.com\/support\/manuals.asp ]"},{"key":"854_CR27","unstructured":"BLAST. [ http:\/\/www.ncbi.nlm.nih.gov\/blast ]"},{"key":"854_CR28","unstructured":"Ingenuity Systems. [ http:\/\/www.ingenuity.com ]"},{"issue":"1","key":"854_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1152\/physiolgenomics.00251.2004","volume":"23","author":"SJ Lee","year":"2005","unstructured":"Lee SJ, Ways JA, Barbato JC, Essig D, Pettee K, DeRaedt SJ, Yang S, Weaver DA, Koch LG, Cicila GT: Gene expression profiling of the left ventricles in a rat model of intrinsic aerobic running capacity. Physiol Genomics. 2005, 23 (1): 62-71. 10.1152\/physiolgenomics.00251.2004.","journal-title":"Physiol Genomics"},{"issue":"7061","key":"854_CR30","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature03985","volume":"437","author":"SE Calvano","year":"2005","unstructured":"Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF: A network-based analysis of systemic inflammation in humans. Nature. 2005, 437 (7061): 1032-1037. 10.1038\/nature03985.","journal-title":"Nature"},{"key":"854_CR31","doi-asserted-by":"crossref","unstructured":"Saban R, D'Andrea MR, Andrade-Gordon P, Derian C, Dozmorov I, Ihnat MA, Hurst RE, Simpson C, Saban MR: Regulatory Network of Inflammation Downstream Proteinase-Activated Receptors. BMC Physiol. 2007, 7 (3):","DOI":"10.1186\/1472-6793-7-3"},{"key":"854_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2172-8-17","volume":"8","author":"R Saban","year":"2007","unstructured":"Saban R, Simpson C, Davis CA, Dozmorov I, Maier J, Fowler B, Ihnat MA, Hurst RE, Wershil BK, Saban MR: Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation. BCM Immunology. 2007, 8: 17-10.1186\/1471-2172-8-17.","journal-title":"BCM Immunology"},{"key":"854_CR33","unstructured":"Genpathway. [ http:\/\/www.genpathway.com ]"},{"issue":"5","key":"854_CR34","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1073\/pnas.0409578102","volume":"102","author":"P Labhart","year":"2005","unstructured":"Labhart P, Karmakar S, Salicru EM, Egan BS, Alexiadis V, O'Malley BW, Smith CL: Identification of target genes in breast cancer cells directly regulated by the SRC-3\/AIB1 coactivator. Proc Natl Acad Sci USA. 2005, 102 (5): 1339-1344. 10.1073\/pnas.0409578102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"854_CR35","unstructured":"[ http:\/\/frodo.wi.mit.edu\/cgi-bin\/primer3\/primer3_www.cgi ]"},{"issue":"12","key":"854_CR36","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1073\/pnas.93.12.6025","volume":"93","author":"L Diatchenko","year":"1996","unstructured":"Diatchenko L, Lau Y-FC, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD: Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. PNAS. 1996, 93 (12): 6025-6030. 10.1073\/pnas.93.12.6025.","journal-title":"PNAS"},{"issue":"1","key":"854_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2164-3-12","volume":"3","author":"W Ji","year":"2002","unstructured":"Ji W, Wright MB, Cai L, Flament A, Lindpaintner K: Efficacy of SSH PCR in isolating differentially expressed genes. BMC Genomics. 2002, 3 (1): 12-10.1186\/1471-2164-3-12.","journal-title":"BMC Genomics"},{"issue":"2","key":"854_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1586\/14737159.3.2.217","volume":"3","author":"MR Saban","year":"2003","unstructured":"Saban MR, Nguyen NB, Hurst RE, Saban R: Gene expression profiling of inflammatory bladder disorders. Expert Rev Mol Diagn. 2003, 3 (2): 217-235. 10.1586\/14737159.3.2.217.","journal-title":"Expert Rev Mol Diagn"},{"issue":"3","key":"854_CR39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physiolgenomics.2001.5.3.147","volume":"5","author":"MR Saban","year":"2001","unstructured":"Saban MR, Hellmich H, Nguyen NB, Winston J, Hammond TG, Saban R: Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics. 2001, 5 (3): 147-160.","journal-title":"Physiol Genomics"},{"issue":"6","key":"854_CR40","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0002-9440(10)61159-5","volume":"160","author":"MR Saban","year":"2002","unstructured":"Saban MR, Nguyen NB, Hammond TG, Saban R: Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol. 2002, 160 (6): 2095-2110.","journal-title":"Am J Pathol"},{"issue":"1","key":"854_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4049\/jimmunol.179.1.211","volume":"179","author":"MS Russell","year":"2007","unstructured":"Russell MS, Iskandar M, Mykytczuk OL, Nash JH, Krishnan L, Sad S: A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guerin). J Immunol. 2007, 179 (1): 211-220.","journal-title":"J Immunol"},{"issue":"6","key":"854_CR42","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.4049\/jimmunol.178.6.3786","volume":"178","author":"M Umemura","year":"2007","unstructured":"Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K, Suda T, Sudo K, Nakae S, Iwakura Y, Matsuzaki G: IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol. 2007, 178 (6): 3786-3796.","journal-title":"J Immunol"},{"key":"854_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev.cellbio.22.010305.104619","volume":"22","author":"S Martens","year":"2006","unstructured":"Martens S, Howard J: The interferon-inducible GTPases. Annu Rev Cell Dev Biol. 2006, 22: 559-589. 10.1146\/annurev.cellbio.22.010305.104619.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"8","key":"854_CR44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1089\/107999002760274926","volume":"22","author":"TT Nguyen","year":"2002","unstructured":"Nguyen TT, Hu Y, Widney DP, Mar RA, Smith JB: Murine GBP-5, a new member of the murine guanylate-binding protein family, is coordinately regulated with other GBPs in vivo and in vitro. J Interferon Cytokine Res. 2002, 22 (8): 899-909. 10.1089\/107999002760274926.","journal-title":"J Interferon Cytokine Res"},{"key":"854_CR45","first-page":"1","volume":"8","author":"P Staeheli","year":"1987","unstructured":"Staeheli P, Haller O: Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus. Interferon. 1987, 8: 1-23.","journal-title":"Interferon"},{"issue":"12","key":"854_CR46","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.4049\/jimmunol.161.12.6715","volume":"161","author":"U Boehm","year":"1998","unstructured":"Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, Futterer A, Pfeffer K, Howard JC: Two families of GTPases dominate the complex cellular response to IFN-gamma. J Immunol. 1998, 161 (12): 6715-6723.","journal-title":"J Immunol"},{"issue":"Pt 9","key":"854_CR47","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1242\/jcs.01039","volume":"117","author":"F Kaiser","year":"2004","unstructured":"Kaiser F, Kaufmann SH, Zerrahn J: IIGP, a member of the IFN inducible and microbial defense mediating 47 kDa GTPase family, interacts with the microtubule binding protein hook3. J Cell Sci. 2004, 117 (Pt 9): 1747-1756. 10.1242\/jcs.01039.","journal-title":"J Cell Sci"},{"issue":"4","key":"854_CR48","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.4049\/jimmunol.173.4.2594","volume":"173","author":"S Martens","year":"2004","unstructured":"Martens S, Sabel K, Lange R, Uthaiah R, Wolf E, Howard JC: Mechanisms regulating the positioning of mouse p47 resistance GTPases LRG-47 and IIGP1 on cellular membranes: retargeting to plasma membrane induced by phagocytosis. J Immunol. 2004, 173 (4): 2594-2606.","journal-title":"J Immunol"},{"issue":"3","key":"854_CR49","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1371\/journal.ppat.0010024","volume":"1","author":"S Martens","year":"2005","unstructured":"Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, Howard JC: Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog. 2005, 1 (3): e24-10.1371\/journal.ppat.0010024.","journal-title":"PLoS Pathog"},{"issue":"15","key":"854_CR50","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1093\/emboj\/cdg382","volume":"22","author":"E Guenzi","year":"2003","unstructured":"Guenzi E, Topolt K, Lubeseder-Martellato C, Jorg A, Naschberger E, Benelli R, Albini A, Sturzl M: The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. Embo J. 2003, 22 (15): 3772-3782. 10.1093\/emboj\/cdg382.","journal-title":"Embo J"},{"key":"854_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.advenzreg.2005.02.011","volume":"45","author":"E Naschberger","year":"2005","unstructured":"Naschberger E, Bauer M, Sturzl M: Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseases. Advances in enzyme regulation. 2005, 45: 215-227. 10.1016\/j.advenzreg.2005.02.011.","journal-title":"Advances in enzyme regulation"},{"issue":"20","key":"854_CR52","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1093\/emboj\/20.20.5568","volume":"20","author":"E Guenzi","year":"2001","unstructured":"Guenzi E, Topolt K, Cornali E, Lubeseder-Martellato C, Jorg A, Matzen K, Zietz C, Kremmer E, Nappi F, Schwemmle M, Hohenadl C, Barillari G, Tschachler E, Monini P, Ensoli B, Sturzl M: The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. Embo J. 2001, 20 (20): 5568-5577. 10.1093\/emboj\/20.20.5568.","journal-title":"Embo J"},{"issue":"11","key":"854_CR53","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/gb-2005-6-11-r92","volume":"6","author":"C Bekpen","year":"2005","unstructured":"Bekpen C, Hunn JP, Rohde C, Parvanova I, Guethlein L, Dunn DM, Glowalla E, Leptin M, Howard JC: The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol. 2005, 6 (11): R92-10.1186\/gb-2005-6-11-r92.","journal-title":"Genome Biol"},{"issue":"1","key":"854_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coi.2005.11.003","volume":"18","author":"L Shen","year":"2006","unstructured":"Shen L, Rock KL: Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol. 2006, 18 (1): 85-91. 10.1016\/j.coi.2005.11.003.","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"854_CR55","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1182\/blood-2006-10-051318","volume":"109","author":"A Perez-Diez","year":"2007","unstructured":"Perez-Diez A, Joncker NT, Choi K, Chan WF, Anderson CC, Lantz O, Matzinger P: CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood. 2007, 109 (12): 5346-5354. 10.1182\/blood-2006-10-051318.","journal-title":"Blood"},{"issue":"8","key":"854_CR56","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00262-004-0653-2","volume":"54","author":"KL Knutson","year":"2005","unstructured":"Knutson KL, Disis ML: Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother. 2005, 54 (8): 721-728. 10.1007\/s00262-004-0653-2.","journal-title":"Cancer Immunol Immunother"},{"issue":"Suppl 1","key":"854_CR57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1399-0039.2006.00776.x","volume":"69","author":"T Rodriguez","year":"2007","unstructured":"Rodriguez T, Aptsiauri N, Mendez R, Jimenez P, Ruiz-Cabello F, Garrido F: Different mechanisms can lead to the same altered HLA class I phenotype in tumors. Tissue antigens. 2007, 69 (Suppl 1): 259-263. 10.1111\/j.1399-0039.2006.00776.x.","journal-title":"Tissue antigens"},{"issue":"7","key":"854_CR58","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00251-006-0111-8","volume":"58","author":"I Maleno","year":"2006","unstructured":"Maleno I, Romero JM, Cabrera T, Paco L, Aptsiauri N, Cozar JM, Tallada M, Lopez-Nevot MA, Garrido F: LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas. Immunogenetics. 2006, 58 (7): 503-510. 10.1007\/s00251-006-0111-8.","journal-title":"Immunogenetics"},{"issue":"4","key":"854_CR59","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1034\/j.1399-0039.2003.00104.x","volume":"62","author":"T Cabrera","year":"2003","unstructured":"Cabrera T, Pedrajas G, Cozar JM, Garrido A, Vicente J, Tallada M, Garrido F: HLA class I expression in bladder carcinomas. Tissue antigens. 2003, 62 (4): 324-327. 10.1034\/j.1399-0039.2003.00104.x.","journal-title":"Tissue antigens"},{"issue":"1","key":"854_CR60","first-page":"57","volume":"12","author":"FA El-Chennawi","year":"2005","unstructured":"El-Chennawi FA, Auf FA, El-Diasty AM, El-Daim MA, El-Sherbiny SM, Ali A, El-Baz M, El-Hameed MA, Paul P, Ibrahim el C, Carosella E, Ghoneim MA: Expression of HLA-G in cancer bladder. The Egyptian journal of immunology\/Egyptian Association of Immunologists. 2005, 12 (1): 57-64.","journal-title":"The Egyptian journal of immunology\/Egyptian Association of Immunologists"},{"issue":"4","key":"854_CR61","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/ijc.20499","volume":"113","author":"JM Romero","year":"2005","unstructured":"Romero JM, Jimenez P, Cabrera T, Cozar JM, Pedrinaci S, Tallada M, Garrido F, Ruiz-Cabello F: Coordinated downregulation of the antigen presentation machinery and HLA class I\/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Int J Cancer. 2005, 113 (4): 605-610. 10.1002\/ijc.20499.","journal-title":"Int J Cancer"},{"issue":"15","key":"854_CR62","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1158\/1078-0432.CCR-06-0595","volume":"12","author":"H Kitamura","year":"2006","unstructured":"Kitamura H, Torigoe T, Honma I, Sato E, Asanuma H, Hirohashi Y, Sato N, Tsukamoto T: Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus calmette-guerin immunotherapy for bladder cancer. Clin Cancer Res. 2006, 12 (15): 4641-4644. 10.1158\/1078-0432.CCR-06-0595.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"854_CR63","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ni1112","volume":"5","author":"A Iwasaki","year":"2004","unstructured":"Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004, 5 (10): 987-995. 10.1038\/ni1112.","journal-title":"Nat Immunol"},{"key":"854_CR64","volume-title":"Mol Phylogenet Evol","author":"A Garcia-Espana","year":"2006","unstructured":"Garcia-Espana A, Chung PJ, Zhao X, Lee A, Pellicer A, Yu J, Sun TT, Desalle R: Origin of the tetraspanin uroplakins and their co-evolution with associated proteins: Implications for uroplakin structure and function. Mol Phylogenet Evol. 2006"},{"issue":"9","key":"854_CR65","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1091\/mbc.E05-02-0136","volume":"16","author":"CC Hu","year":"2005","unstructured":"Hu CC, Liang FX, Zhou G, Tu L, Tang CH, Zhou J, Kreibich G, Sun TT: Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking. Mol Biol Cell. 2005, 16 (9): 3937-3950. 10.1091\/mbc.E05-02-0136.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"854_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1078\/0171-9335-00351","volume":"83","author":"P Veranic","year":"2004","unstructured":"Veranic P, Romih R, Jezernik K: What determines differentiation of urothelial umbrella cells?. Eur J Cell Biol. 2004, 83 (1): 27-34. 10.1078\/0171-9335-00351.","journal-title":"Eur J Cell Biol"},{"issue":"18","key":"854_CR67","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1073\/pnas.93.18.9630","volume":"93","author":"XR Wu","year":"1996","unstructured":"Wu XR, Sun TT, Medina JJ: In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc Natl Acad Sci USA. 1996, 93 (18): 9630-9635. 10.1073\/pnas.93.18.9630.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"854_CR68","doi-asserted-by":"publisher","first-page":"9924","DOI":"10.1074\/jbc.M008610200","volume":"276","author":"J Pak","year":"2001","unstructured":"Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR: Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem. 2001, 276 (13): 9924-9930. 10.1074\/jbc.M008610200.","journal-title":"J Biol Chem"},{"issue":"Pt 22","key":"854_CR69","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1242\/jcs.114.22.4095","volume":"114","author":"G Zhou","year":"2001","unstructured":"Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu XR, Sun TT, Kong XP: Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci. 2001, 114 (Pt 22): 4095-4103.","journal-title":"J Cell Sci"},{"issue":"21","key":"854_CR70","doi-asserted-by":"publisher","first-page":"14644","DOI":"10.1074\/jbc.M600877200","volume":"281","author":"B Xie","year":"2006","unstructured":"Xie B, Zhou G, Chan SY, Shapiro E, Kong XP, Wu XR, Sun TT, Costello CE: Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia. J Biol Chem. 2006, 281 (21): 14644-14653. 10.1074\/jbc.M600877200.","journal-title":"J Biol Chem"},{"key":"854_CR71","volume-title":"Cytokine & growth factor reviews","author":"TL Nagabhushan","year":"2007","unstructured":"Nagabhushan TL, Maneval DC, Benedict WF, Wen SF, Ihnat PM, Engler H, Connor RJ: Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer. Cytokine & growth factor reviews. 2007"},{"issue":"1","key":"854_CR72","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1365-2249.2007.03413.x","volume":"149","author":"X Chen","year":"2007","unstructured":"Chen X, O'Donnell MA, Luo Y: Dose-dependent synergy of Th1-stimulating cytokines on bacille Calmette-Guerin-induced interferon-gamma production by human mononuclear cells. Clin Exp Immunol. 2007, 149 (1): 178-185.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"854_CR73","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/cncr.22503","volume":"109","author":"K Esuvaranathan","year":"2007","unstructured":"Esuvaranathan K, Chiong E, Thamboo TP, Chan YH, Kamaraj R, Mahendran R, Teh M: Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha. Cancer. 2007, 109 (6): 1097-1105. 10.1002\/cncr.22503.","journal-title":"Cancer"},{"issue":"4","key":"854_CR74","first-page":"3189","volume":"13","author":"PI Karakiewicz","year":"2006","unstructured":"Karakiewicz PI, Benayoun S, Lewinshtein DJ, Chun FK, Shahrour K, Perrotte P: Treatment of BCG failures with intravesical BCG\/Interferon: the University of Montreal experience. The Canadian journal of urology. 2006, 13 (4): 3189-3194.","journal-title":"The Canadian journal of urology"},{"issue":"4","key":"854_CR75","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.urolonc.2005.11.026","volume":"24","author":"FN Joudi","year":"2006","unstructured":"Joudi FN, Smith BJ, O'Donnell MA: Final results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer. Urol Oncol. 2006, 24 (4): 344-348.","journal-title":"Urol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-7-204\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-7-204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-7-204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-7-204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T16:04:10Z","timestamp":1684080250000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-7-204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,2]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["854"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-7-204","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,2]]},"article-number":"204"}}